Cargando…
Risk scores for predicting early antiretroviral therapy mortality in sub-Saharan Africa to inform who needs intensification of care: a derivation and external validation cohort study
BACKGROUND: Clinical scores to determine early (6-month) antiretroviral therapy (ART) mortality risk have not been developed for sub-Saharan Africa (SSA), home to 70% of people living with HIV. In the absence of validated scores, WHO eligibility criteria (EC) for ART care intensification are CD4 <...
Autores principales: | Auld, Andrew F., Fielding, Katherine, Agizew, Tefera, Maida, Alice, Mathoma, Anikie, Boyd, Rosanna, Date, Anand, Pals, Sherri L., Bicego, George, Liu, Yuliang, Shiraishi, Ray W., Ehrenkranz, Peter, Serumola, Christopher, Mathebula, Unami, Alexander, Heather, Charalambous, Salome, Emerson, Courtney, Rankgoane-Pono, Goabaone, Pono, Pontsho, Finlay, Alyssa, Shepherd, James C., Holmes, Charles, Ellerbrock, Tedd V., Grant, Alison D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650165/ https://www.ncbi.nlm.nih.gov/pubmed/33161899 http://dx.doi.org/10.1186/s12916-020-01775-8 |
Ejemplares similares
-
Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial
por: Auld, Andrew F., et al.
Publicado: (2020) -
Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study
por: Auld, Andrew F., et al.
Publicado: (2021) -
Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria
por: Agizew, Tefera, et al.
Publicado: (2020) -
Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay
por: Agizew, Tefera, et al.
Publicado: (2017) -
Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial
por: Agizew, Tefera, et al.
Publicado: (2019)